FBLG · FibroBiologics, Inc.
$1.76
-0.19 (-9.74%)
At close · Sep 3
Going-concern doubt
— flagged Jul 31, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern for one year from the issuance of the condensed consolidated financial statements. While management has implemented plans to obtain additional funding, these plans are not sufficient to alleviate the substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Jul 31, 2026
Market Cap
$12.98M
Shares
6.66M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding FBLG
6 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND | — | 27,769 | $26,317 | 0.00% | Long | 2026-06-30 | |
| Fidelity Extended Market Index Fund | FSMAX | 19,544 | $22,671 | 0.00% | Long | 2026-05-31 | |
| Small-Mid Cap Equity Fund | TSGUX | 1,292 | $3,385 | 0.00% | Long | 2024-11-30 | |
| Fidelity Series Total Market Index Fund | FCFMX | 2,571 | $2,982 | 0.00% | Long | 2026-05-31 | |
| Fidelity Total Market Index Fund | FSKAX | 2,266 | $2,629 | 0.00% | Long | 2026-05-31 | |
| Fidelity Nasdaq Composite Index Fund | FNCMX | 1,099 | $1,275 | 0.00% | Long | 2026-05-31 |
Showing 1–6 of 6 positions
Key facts
CIK
1958777
CUSIP
31573L204
13F (30d)
15 filings
15 filers
Visit website
Investor relations